| Name | Mirikizumab |
|---|
| Description | Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody targets the p19 subunit of interleukin 23. Mirikizumab can be used for the research of ulcerative colitis[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |